Source:http://linkedlifedata.com/resource/pubmed/id/21579908
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt 1
|
pubmed:dateCreated |
2011-5-17
|
pubmed:abstractText |
In the title compound, {[Cu(C(6)H(2)N(2)O(4))(C(3)H(7)NO)]·H(2)O}(n), the Cu(II) atom is coordinated by an N,O-bidentate pyrazine-2,3-dicarboxyl-ate (pzdc) dianion, two O atoms from two other pzdc anions and one O atom from the dimethlyformamide ligand, forming a distorted square-pyramidal CuNO(4) geometry. The polymeric character of the structure is established by the formation of layers parallel to (100) via bridging pzdc ligands. O-H?O hydrogen bonding between water mol-ecules and uncoordinated carboxyl-ate O atoms leads to additional stabilization of the structure.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:issn |
1600-5368
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
m10-1
|
pubmed:dateRevised |
2011-11-11
|
pubmed:year |
2009
|
pubmed:articleTitle |
Poly[[(N,N-dimethyl-formamide-?O)(?(3)-pyrazine-2,3-dicarboxyl-ato-?N,O:O:O)copper(II)] monohydrate].
|
pubmed:publicationType |
Journal Article
|